Therefore, DPP-4 inhibitors extend the half-life of endogenous GLP-1 lead to a 2threefold elevation of endogenous GLP-1 concentration, and provide beneficial effects in T2DM [110, 111]
The best choice aligns with individual response and sustainable care
Contraindications and Use Restrictions GLP-1 medications should not be used by individuals with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, known hypersensitivity to semaglutide, or during pregnancy or breastfeeding
Although Azithromycin has a comparatively lower interaction profile, caution is still advised in: Elderly patients Patients with cardiovascular disease Individuals with hepatic or renal impairment Patients at risk of QT prolongation Safer statin options with fewer interactions may include Rosuvastatin and Pravastatin
Regular monitoring and open communication with your healthcare team are essential throughout Wegovy treatment